Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mathias

Showing results (151-160 of 160) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 160 results.
Biomarker Research|February 15, 2017
A case report of concurrent embryonal rhabdomyosarcoma and diffuse large B-cell lymphoma in an adult without identifiable cancer predispositionM D Mathias, M V Ortiz, H Magnan, et al.
The Journal of Physical Chemistry. B|August 16, 2014
Characterizing solution surface loop conformational flexibility of the GM2 activator proteinJeffery D Carter, Jordan D Mathias, Edwin F Gomez, et al.
Health and Quality of Life Outcomes|February 12, 2008
Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspectiveSusan D Mathias, Sue K Gao, Kimberly L Miller, et al.
Cancer|August 23, 2022
Perceptions of patient disease burden and management approaches in systemic mastocytosis: Results of the TouchStone Healthcare Provider SurveyRuben A Mesa, Erin M Sullivan, David Dubinski, et al.
Cancer|August 23, 2022
Patient-reported outcomes among patients with systemic mastocytosis in routine clinical practice: Results of the TouchStone SM Patient SurveyRuben A Mesa, Erin M Sullivan, David Dubinski, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2024
Qualitative and Psychometric Evaluation of 29-Item Patient-Reported Outcomes Measurement Information System® to Assess General Health-Related Quality of Life in Patients With Moderately to Severely Active Inflammatory Bowel DiseaseBruce E Sands, Julian Panés, Brian G Feagan, et al.
The Journal of Clinical Investigation|June 20, 2017
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigensAaron Y Chang, Tao Dao, Ron S Gejman, et al.
Pediatrics|August 2, 2019
Local Anesthesia With General Anesthesia for Pediatric Bone Marrow ProceduresSara Zarnegar-Lumley, Katharine R Lange, Melissa D Mathias, et al.
BMC Cancer|May 30, 2021
Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE studyStéphane Dalle, Laurent Mortier, Pippa Corrie, et al.
Cancer|September 7, 2012
Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acidCharles S Cleeland, Jean-Jacques Body, Alison Stopeck, et al.
Pageof 16

Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Biomarker Research|February 15, 2017
A case report of concurrent embryonal rhabdomyosarcoma and diffuse large B-cell lymphoma in an adult without identifiable cancer predispositionM D Mathias, M V Ortiz, H Magnan, et al.
The Journal of Physical Chemistry. B|August 16, 2014
Characterizing solution surface loop conformational flexibility of the GM2 activator proteinJeffery D Carter, Jordan D Mathias, Edwin F Gomez, et al.
Health and Quality of Life Outcomes|February 12, 2008
Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspectiveSusan D Mathias, Sue K Gao, Kimberly L Miller, et al.
Cancer|August 23, 2022
Perceptions of patient disease burden and management approaches in systemic mastocytosis: Results of the TouchStone Healthcare Provider SurveyRuben A Mesa, Erin M Sullivan, David Dubinski, et al.
Cancer|August 23, 2022
Patient-reported outcomes among patients with systemic mastocytosis in routine clinical practice: Results of the TouchStone SM Patient SurveyRuben A Mesa, Erin M Sullivan, David Dubinski, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2024
Qualitative and Psychometric Evaluation of 29-Item Patient-Reported Outcomes Measurement Information System® to Assess General Health-Related Quality of Life in Patients With Moderately to Severely Active Inflammatory Bowel DiseaseBruce E Sands, Julian Panés, Brian G Feagan, et al.
The Journal of Clinical Investigation|June 20, 2017
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigensAaron Y Chang, Tao Dao, Ron S Gejman, et al.
Pediatrics|August 2, 2019
Local Anesthesia With General Anesthesia for Pediatric Bone Marrow ProceduresSara Zarnegar-Lumley, Katharine R Lange, Melissa D Mathias, et al.
BMC Cancer|May 30, 2021
Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE studyStéphane Dalle, Laurent Mortier, Pippa Corrie, et al.
Cancer|September 7, 2012
Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acidCharles S Cleeland, Jean-Jacques Body, Alison Stopeck, et al.
Pageof 16